Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02747160 · ClinicalTrials.gov registry record · NA

Anxiety With Cancer in the Elderly (ACE): A Cognitive-behavioral Intervention

A NA study, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT02747160: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT02747160 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02747160, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

The purpose of this study is to examine the feasibility and acceptability of and patient adherence to a telephone-administered cognitive-behavioral therapy intervention for anxiety in older adults (65 years and older) with cancer and their primary informal caregiver. This study will also examine whether the intervention has a clinically significant impact on patient anxiety (primary outcome) and depression, distress, and quality of life (secondary outcomes).

Primary Outcome

Attrition rates

Interventions

  • BEHAVIORAL Managing Anxiety from Cancer (MAC)

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2016-06
Est. Completion 2020-07-02
Phase NA
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT02747160 record still lists

NCT02747160 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Managing Anxiety from Cancer (MAC) is the first listed.

NCT02747160 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02747160 about?

NCT02747160 is a clinical study titled "Anxiety With Cancer in the Elderly (ACE): A Cognitive-behavioral Intervention". The purpose of this study is to examine the feasibility and acceptability of and patient adherence to a telephone-administered cognitive-behavioral therapy intervention for anxiety in older adults (65 years and older) with cancer and their primary informal caregiver. This study will also examine whe...

What is the current status of trial NCT02747160?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-06. Estimated completion is 2020-07-02.

What interventions are being tested in trial NCT02747160?

The interventions under investigation include: Managing Anxiety from Cancer (MAC) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02747160?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02747160's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02747160, the US trial registry maintained by the National Library of Medicine. NCT02747160 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.